These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15620146)

  • 81. [Hexosoaminidase gene expression in cholesteatoma in adults].
    Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
    Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical and biochemical studies of bone destruction in cholesteatoma.
    Amar MS; Wishahi HF; Zakhary MM
    J Laryngol Otol; 1996 Jun; 110(6):534-9. PubMed ID: 8763371
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Temporal bone histopathology case of the month. First branchial cleft anomaly with an orifice in the bony external auditory canal accompanied by contralateral middle ear cholesteatoma.
    Ohki M; Baba Y; Ohata A
    Otol Neurotol; 2015 Feb; 36(2):e70-2. PubMed ID: 24770409
    [No Abstract]   [Full Text] [Related]  

  • 84. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.
    Bujía J; Kim C; Ostos P; Sudhoff H; Kastenbauer E; Hültner L
    Eur Arch Otorhinolaryngol; 1996; 253(4-5):252-5. PubMed ID: 8737779
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin.
    Banerjee AR; Jones JL; Birchall JP; Powe DG
    Otol Neurotol; 2001 Sep; 22(5):579-81. PubMed ID: 11568661
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Characteristics of diagnosis and surgical treatment of various forms of congenital temporal bone cholesteatoma].
    Anikin IA; Khamgushkeeva NN; Knyazev AD; Konoplev OI
    Vestn Otorinolaringol; 2020; 85(3):23-27. PubMed ID: 32628378
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Microsurgical efficacy of cholesteatoma of external auditory canal combined with filling drugs by ear endoscopy].
    Zhang F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 28(10):741-2. PubMed ID: 25129981
    [No Abstract]   [Full Text] [Related]  

  • 88. Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays.
    Klenke C; Janowski S; Borck D; Widera D; Ebmeyer J; Kalinowski J; Leichtle A; Hofestädt R; Upile T; Kaltschmidt C; Kaltschmidt B; Sudhoff H
    PLoS One; 2012; 7(12):e52718. PubMed ID: 23285167
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
    Chung JW; Yoon TH
    Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
    [TBL] [Abstract][Full Text] [Related]  

  • 90. MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells.
    Lavini-Ramos C; Silva HM; Soares-Schanoski A; Monteiro SM; Ferreira LRP; Pacanaro AP; Gomes S; Batista J; Faé K; Kalil J; Coelho V
    Sci Rep; 2017 Apr; 7(1):874. PubMed ID: 28408751
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [2 Cases of cholesteatoma of the external auditory meatus with atypical course].
    Anusz R
    Otolaryngol Pol; 1966; 20(2):349-51. PubMed ID: 5950176
    [No Abstract]   [Full Text] [Related]  

  • 92. Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates.
    Kratz F; Drevs J; Bing G; Stockmar C; Scheuermann K; Lazar P; Unger C
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2001-6. PubMed ID: 11454467
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Advances in research on apoptosis in the pathogenesis of acquired middle ear cholesteatoma].
    Song SP; Li WW; Ma XL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jun; 33(6):572-576. PubMed ID: 31163540
    [No Abstract]   [Full Text] [Related]  

  • 94. Cholesteatoma of the external auditory canal; report of two cases.
    LINEBACK M
    Eye Ear Nose Throat Mon; 1960 Nov; 39():888-91. PubMed ID: 13762410
    [No Abstract]   [Full Text] [Related]  

  • 95. Esterases of postauricular and ear canal skin, compared with cholesteatoma epithelium.
    Palva T; Raunio V; Forsén R; Palva A
    Acta Otolaryngol; 1971 Nov; 72(5):329-35. PubMed ID: 5146006
    [No Abstract]   [Full Text] [Related]  

  • 96. Localization of prostaglandin-forming cyclooxygenase in middle ear and external canal tissue.
    Jung TT; Juhn SK; Michael AF
    Otolaryngol Head Neck Surg; 1983 Apr; 91(2):187-92. PubMed ID: 6408577
    [No Abstract]   [Full Text] [Related]  

  • 97. An in vitro growth study on cholesteatoma and normal skin.
    Cheshire IM; Blight A; Proops DW
    Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):453-60. PubMed ID: 8582080
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Complication of dilute vinegar therapy for external auditory canal cholesteatoma.
    Leong AC; Bowdler DA
    Eur Arch Otorhinolaryngol; 2012 Oct; 269(10):2301. PubMed ID: 22576245
    [No Abstract]   [Full Text] [Related]  

  • 99. Reply to the Letter to the Editor regarding "Etiopathogenesis of bone resorption in acquired middle ear cholesteatoma".
    Xie S; Liu W; Ren J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4253. PubMed ID: 28791463
    [No Abstract]   [Full Text] [Related]  

  • 100. Primary aural cholesteatoma.
    VOLK BM
    AMA Arch Otolaryngol; 1951 Jun; 53(6):662-7. PubMed ID: 14837556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.